Background {#Sec1}
==========

Coronary heart disease (CHD), a multifactorial heart disorder resulting from both environmental and genetic factors \[[@CR1]\], is one of the leading causes of disability and death around the world \[[@CR2]\]. Epidemiology studies have suggested that hypertension, hyperlipidemia, diabetes mellitus, obesity and smoking are major risk factors for CHD \[[@CR3]\]. In recent years, more and more studies reveled that several loci and variants are strongly associated with CHD \[[@CR4], [@CR5]\]. It has been estimated that approximately 50% of the variability of the major risk factors for CHD is determined by genetics \[[@CR6]\].

The KIF6 protein is one of several molecular components that mediate intracellular transport of organelles, protein complexes, and mRNAs. A common Trp719Arg (rs20455) SNP in exon 19 of the KIF6 gene has been identified as a potential risk factor for CHD \[[@CR7], [@CR8]\]. The KIF6 protein belongs to the kinesin superfamily, which is involved in the intracellular transport in a microtubule and ATP-dependent manner \[[@CR9]\]. The rs20455 polymorphism replaces the nonpolar 'Trp' residue in codon 719 with a basic 'Arg' amino acid. This SNP lies near the putative cargo binding taildomain and may alter the cargo activity of KIF6 \[[@CR10]\]. Carriers of the 719Arg allele exhibit a 50% increased risk of events compared with non-carriers \[[@CR8], [@CR11]\]. Up to now, multiple large prospective and case--control studies have reported the association between KIF6 rs20455 polymorphism and the risk of CHD. However, somestudies have not verified inconsistent results. Published studies have generally been restricted in terms of sample size and ethnic diversity, and individual studies may have in-sufficient power to achieve a comprehensive and reliable conclusion. In view of the discrepancies in the findings of previous published studies, we aimed to perform a meta-analysis of the published studies to clarify the association between KIF6 rs20455 polymorphism and CHD to get a better under-standing of this relationship.

Methods {#Sec2}
=======

Literature search {#Sec3}
-----------------

A comprehensive search for all related studies from both electric databases, such as, Medline (mainly PubMed), Embase, Web of science, China National Knowledge Infrastructure (CNKI) et al., and hand search from references of all eligible literatures. Single or combinations of the following keywords were used: "kinesin like protein 6" or "KIF6" or "rs20455" or "719Arg", "single nucleotide polymorphism, SNP or variation, mutation", "genetic association" and "coronary heart disease" or "CHD". No language and sample size were set. When more than one studies of the same population were included in several publications, only the most recent or complete studies were included in this meta-analysis.

Selection criteria {#Sec4}
------------------

Articles included should meet following criteria: an appropriate description of KIF6 rs20455 polymorphism in CHD cases and healthy controls; results expressed as odds ratio (OR); and studies with a 95% confidence interval (CI) for OR with sufficient data to calculate these numbers. While for the exclusion criteria provided as follows: studies without raw data; case-only studies, family-based studies, case reports, editorials, and review articles (including meta-analyses). In studies with overlapping cases/controls, the study with the higher quality score or the study with more information on the origin of the cases/controls was included in the meta-analysis.

Data extraction {#Sec5}
---------------

Two researchers extracted important information independently and carefully from all eligible studies according to the criteria listed above. Any disagreement will be resolved by the two authors through discussion or the third author. The following data were extracted from each included study: first author's surname, year of publication, country, ethnicity, genotyping method, source of control, total number of cases and controls, distributions of KIF6 rs20455 genotypes. Different ethnicity descents were categorized as Caucasian, Asian, and Mixed populations (the original studies didn't clarify the race of the subjects or mixed races).

Statistical analysis {#Sec6}
--------------------

We adopted poled ORs and corresponding 95% confidence interval (CIs) to detect the association between KIF6 rs20455 polymorphism and CHD risk. Heterogeneity was explored by Q statistic \[[@CR12]\], and the *P* value was \<0.05 will be considered statistically significant. Heterogeneity was also assessed using the *I*^*2*^ statistic, which takes values between 0% and 100% with higher values denoting greater degree of heterogeneity (*I*^*2*^ = 0--25%: noheterogeneity; *I*^*2*^ = 25--50%: moderate heterogeneity; *I*^*2*^ = 50--75%: large heterogeneity; *I*^*2*^ = 75--100%: extreme heterogeneity) \[[@CR13]\]. Different statistical models will be selected according to the result of heterogeneity. Random (Der Simonian-Laird method) \[[@CR14]\] will be used to calculate the precise results when the *P* value of heterogeneity was \<0.05, or the *I*^*2*^ \> 50%. Otherwise, fixed effects model (Mantel-Haenszel method) will be adopted \[[@CR15]\]. Five genetic comparison model were carried out and calculated as follows: homozygote model (GG vs. AA), heterozygote model (AG vs. AA), recessive model (GG vs. AG + AA), and dominant model (GG + AG vs. AA), and allele comparison model (G-allele vs. A-allele). Hardy--Weinberg equilibrium in the control group was tested by the chi-square test for goodness of fit, and a *P* value of \<0.05 was considered significant. Subgroup analyses were performed by ethnicity, source of control, to confirm if our results were stable and robust \[[@CR16]\]. Begg's funnel plots \[[@CR17]\] and Egger's test \[[@CR18]\] were explored to examine if potential publication bias were existed in this study. Sensitivity analysis was carried out by sequentially omitting each study and finding the influence on the overall summary estimate \[[@CR19]\]. All the statistical analyses were finished by STATA software (version 12.0; Stata Corporation, College Station, TX). All the *P* values were two-sided.

Results {#Sec7}
=======

Characteristics of all included studies {#Sec8}
---------------------------------------

Totally, 209 potential relevant studies were searched through several databases. Based on the including criteria listed above, only 28 articles including 50 separate studies were included finally \[[@CR8], [@CR20]--[@CR46]\]. A flow diagram summarizing the process of study selection was present in Fig. [1](#Fig1){ref-type="fig"}. The baseline characteristics ofall included studies were listed in Table [1](#Tab1){ref-type="table"}. Helgadottir et al. contained two individual studies \[[@CR25]\], Samani et al. contained two individual studies \[[@CR26]\], Assimes et al. contained 20 individual studies \[[@CR31]\], and Wu et al. contained two separate studies \[[@CR41]\]. Moreover, there were 37 studies from Caucasian decedent, 9 studies from Asian populations and the rest 14 studies from mixed populations. There were 20 population-based (PB) studies, 21 hospital-based (HB) studies and four family based (FB) study, three community based (CB) study, two hospital and community based (H-CB) study. Different ethnicity descents were categorized as Caucasian, Asian and Mix (the original studies didn't clarify the race of the subjects or mixed races).Fig. 1The process of literature researchTable 1Characteristics of all studies included in this meta-analysisAuthorYearCountryEthnicityControl sourceCaseControlCaseControl*P* ~*HWE*~AAAGGGAAAGGGBerglund et al.1993SwedenCaucasianPB8699353813335412YesVartiainen et al.2000FinlandCaucasianPB167172648122737623YesSenti et al.2001SpainCaucasianPB3123171341393914113739YesYusuf et al.2004SeveralAsianPB10921187351498243389531267YesLow et al.2005USACaucasianHB20426089862911411135YesHelgadottir et al.^1^2007USACaucasianPB87544737039910617422152YesHelgadottir et al.^2^2007USACaucasianPB93346835944113319421361YesSamani et al.^1^2007GermanyCaucasianPB11261277447529150522593162YesSamani et al.^2^2007GermanyCaucasianPB7221643293328101662753228YesMeng et al.2008IrelandCaucasianFB4826222032265326129269YesMeiner et al.2008USACaucasianPB5055591872289021626083YesSerre et al.2008SeveralMixedPB789859335337117354402103YesMorgan et al.2008USACaucasianHB80763732237710825630477YesAssimes et al.2008USACaucasianPB50551416218783144183130YesVennemann et al.2008GermanyCaucasianPB7931121311379103430528163YesSutton et al.2008USACaucasianFB157597054557018329734786YesMartinelli et al.2008ItalyCaucasianPB110638343750116814519147YesIakoubova et al.2008ScottlandCaucasianPB48110801041373525620459YesStewart et al.2009CanadaCaucasianHB15401455183695662205616634YesLuke et al.2009AustriaCaucasianHB50578273254178102373307YesBare et al.2010Costa RicanCaucasianPB19872147785952250896966285YesAssimes et al.^1^2010U.S.AMixedPB50551419222093161213140YesAssimes et al.^2^2010GermanyCaucasianHB7931121311379103430528163YesAssimes et al.^3^2010U.S.AMixedHB1575970561670344306433231YesAssimes et al.^4^2010IcelandCaucasianPB431324,9522131177940311,81310,6892450YesAssimes et al.^5^2010FinlandCaucasianPB167172648122737623YesAssimes et al.^6^2010U.S.AMixedFB3782652108182886791105868YesAssimes et al.^7^2010GermanyCaucasianPB7221643293328101662753228YesAssimes et al.^8^2010GermanyCaucasianHB11261277447529150522593162YesAssimes et al.^9^2010U.S.ACaucasianCB5055591872289021626083YesAssimes et al.^10^2010MixedCaucasianH-CB789859335337117354402103YesAssimes et al.^11^2010MixedAsianH-CB10921187351498243389531267YesAssimes et al.^12^2010IrelandCaucasianFB4826222032265326129269YesAssimes et al.^13^2010SwedenCaucasianPB8699353813335412YesAssimes et al.^14^2010U.S.ACaucasianHB87544737039910317422152YesAssimes et al.^15^2010U.S.ACaucasianHB20426089862911411135YesAssimes et al.^16^2010U.S.ACaucasianHB80763732237710825630477YesAssimes et al.^17^2010U.S.ACaucasianHB93346835944113319421361YesAssimes et al.^18^2010SpainCaucasianCB3123171341393914113739YesAssimes et al.^19^2010ItalyCaucasianHB110638343750116814519147YesAssimes et al.^20^2010U.K.CaucasianCB1922293379289024012421299392YesBhanushali et al.2011IndiaAsianHB2271507011146338037YesPeng et al.2012ChinaAsianHB2895226914971139262121YesWu et al.^1^2012ChinaAsianHB35656810416488168268132YesWu et al.^2^2012ChinaAsianHB114568166830168268132YesWu et al.2014ChinaAsianHB288346741417310116679YesHamidizadeh et al.2015IranCaucasianHB100100354817632710NoVishnuprabu et al.2015IndiaAsianHB510532107252151121251160YesHubacek et al.2016CzechCaucasianHB18891191691856302440543195YesVatte et al.2016Saudi ArabiaAsianHB1002984277513212286464234Yes1--20: represents different studies in one publication; *HB* hospital based study, *PB* population based study, *FB* family based study, *CB* community based study, *H-CB* hospital and community based study, *HWE* Hardy-Weinberg equilibrium. Mix: the original studies didn't clarify the race of the subjects or mixed races

Quantitative synthesis {#Sec9}
----------------------

All the eligible data were calculated and significant heterogeneity was detected under homozygote (*I*^*2*^ = 33.9%; P~heterogeneity~ = 0.012), heterozygote (*I*^*2*^ = 35.5%; P~heterogeneity~ = 0.008), dominant (*I*^*2*^ = 39.8; P~heterogeneity~ = 0.002), recessive (*I*^*2*^ = 26.5%; P~heterogeneity~ = 0.047) and allele comparison model (*I*^*2*^ = 44.2%; P~heterogeneity~ = 0.001) between this gene variation and the risk of CHD. So, random-effect model was used to calculate the statistical parameters. Overall, there were no significant association existed between KIF6 rs20455 polymorphism and the risk of CHD (Homozygote model: OR = 1.007, 95% CI =0.952--1.066, *P* = 0.801, Fig. [2](#Fig2){ref-type="fig"}; Heterozygote model: OR = 1.009, 95% CI = 0.968--1.052, *P* = 0.636, Fig. [3](#Fig3){ref-type="fig"}; Dominant model: OR = 1.007, 95% CI = 0.966--1.048, *P* = 0.753, Fig. [4](#Fig4){ref-type="fig"}; Recessive model: OR = 0.989, 95% CI = 0.943--1.037, *P* = 0.655, Fig. [5](#Fig5){ref-type="fig"}; Allele comparison model: OR = 1.00, 95% CI = 0.971--1.030, *P* = 0.988, Fig. [6](#Fig6){ref-type="fig"}). Furthermore, we explored the subgroup analyses by ethnicity and source of control. All the results were listed in Table [2](#Tab2){ref-type="table"}.Fig. 2Forest plot of the association between KIF6 rs20455 gene polymorphism and CHD risk (under homozygote model)Fig. 3Forest plot of the association between KIF6 rs20455 gene polymorphism and CHD risk (under heterozygote model)Fig. 4Forest plot of the association between KIF6 rs20455 gene polymorphism and CHD risk (under dominant model)Fig. 5Forest plot of the association between KIF6 rs20455 gene polymorphism and CHD risk (under recessive model)Fig. 6Forest plot of the association between KIF6 rs20455 gene polymorphism and CHD risk (under allele comparison model)Table 2Main results of pooled ORs with 95% CI in the meta-analysisVariablesNo.P~heterogneity~Analysis modelOR (95% CI)PP~Begg's~P~Egger's~Homozygote model*Total*500.012Random model1.007 (0.952--1.066)0.8010.1060.108*Ethnicity* Caucasian370.45Fixed model1.012 (0.964--1.063)0.622 Asian90.158Fixed model1.038 (0.933--1.154)0.494 Mixed40.004Random model0.771 (0.57--1.043)0.0731*Source of control* PB200.038Random model0.981 (0.895--1.076)0.691 HB210.096Fixed model1.027 (0.956--1.103)0.891 FB40.038Fixed model0.907 (0.767--1.072)0.016 CB30.427Fixed model1.019 (0.872--1.189)0.816 H-CB20.368Fixed model1.073 (0.895--1.286)0.446Heterozygote model*Total*500.008Random model1.009 (0.968--1.052)0.6360.0890.070*Ethnicity* Caucasian370.035Random model0.955 (0.963--1.029)0.790 Asian90.071Fixed model1.089 (0.995--1.191)0.065 Mixed40.639Fixed model0.893 (0.799--0.999)0.047*Source of control* PB200.067Random model0.979 (0.938--1.021)0.316 HB210.004Random model1.040 (0.956--1.132)0.356 FB40.807Fixed model0.966 (0.859--1.085)0.558 CB30.924Fixed model1.064 (0.957--1.183)0.254 H-CB20.265Fixed model0.967 (0.841--1.112)0.637Dominant model*Total*500.002Random model1.007 (0.966--1.048)0.7530.0610.058*Ethnicity* Caucasian370.034Random model1.013 (0.970--1.057)0.568 Asian90.054Fixed model1.071 (0.984--1.165)0.112 Mixed40.508Fixed model0.854 (0.770--0.947)0.003*Source of control* PB200.026Random model0.991 (0.932--1.055)0.786 HB210.002Random model1.040 (0.958--1.129)0.346 FB40.820Fixed model0.948 (0.848--1.059)0.342 CB30.986Fixed model1.053 (0.953--1.164)0.310 H-CB20.551Fixed model0.993 (0.871--1.132)0.917Recessive model*Total*500.047Random model0.989 (0.943--1.037)0.6550.0250.040*Ethnicity* Caucasian370.541Fixed model1.002 (0.959--1.048)0.919 Asian90.819Fixed model0.983 (0.898--1.075)0.705 Mixed4\<0.001Random model0.811 (0.592--1.111)0.191*Source of control* PB200.040Random model0.982 (0.902--1.069)0.668 HB210.796Fixed model0.989 (0.919--1.064)0.715 FB40.004Random model0.924 (0.661--1.291)0.643 CB30.287Fixed model1.009 (0.843--1.209)0.883 H-CB20.142Fixed model1.099 (0.856--1.412)0.395Allele comparison model*Total*500.001Random model1.00 (0.971--1.030)0.9880.0520.066*Ethnicity* Caucasian370.067Fixed model0.999 (0.977--1.022)0.950 Asian90.186Fixed model1.022 (0.968--1.079)0.428 Mixed40.009Random model0.855 (0.742--0.985)\<0.001*Source of control* PB200.004Random model0.990 (0.943--1.040)0.690 HB210.017Random model1.015 (0.967--1.066)0.547 FB40.045Random model0.877 (0.691--1.113)0.361 CB30.653Fixed model1.025 (0.953--1.102)0.507 H-CB20.776Fixed model1.019 (0.931--1.115)0.687*No*. number of studies, *OR* odds ratio, *95% CI* 95% confidence interval, *HB* hospital based study, *PB* population based study, *FB* family based study, *CB* community based study, *H-CB* hospital and community based study

Sensitivity analysis {#Sec10}
--------------------

The sensitivity analysis was performed to evaluate the influence of each individual study on the pooled OR by omitting every single study. The analysis results reflected that our results were statistically stable and reliable.

Publication bias {#Sec11}
----------------

There was no significant publication bias found in the meta-analysis, reflected by *P* values from Begg's correlation (Heterozygote model: *P* = 0.089; Dominant model: *P* = 0.061; Allele comparison model: *P* = 0.052, Fig. [7](#Fig7){ref-type="fig"}) and Egger's regression (Heterozygote model: *P* = 0.070; Dominant model: *P* = 0.058; Allele comparison model: *P* = 0.066, Fig. [8](#Fig8){ref-type="fig"}). However, significant publication bias found in the meta-analysis, reflected by P values from Begg's correlation (Homozygote model: *P* = 0.046; Recessive model: *P* = 0.025) and Egger's regression (Homozygote model: *P* = 0.041; Recessive model: *P* = 0.040). All the results are listed in Table [2](#Tab2){ref-type="table"}.Fig. 7Begg's test of the association between KIF6 rs20455 gene polymorphism and CHD risk (under allele comparison model)Fig. 8Egger's test the association between KIF6 rs20455 gene polymorphism and CHD risk (under allele comparison model)

Discussion {#Sec12}
==========

Large sample and unbiased epidemiological studies of predisposition genes polymorphisms could provide insight into the in vivo relationship between candidate genes and complex diseases. Many epidemiological studies have investigated the relationship between the KIF6 rs20455 polymorphism and the risk of CHD, but because of small sample size and the low statistical power of individual studies, results have been contradictory. In this present study, we searched all eligible studies to date and got the precise result if KIF6 rs20455 polymorphism could contribute to the risk of CHD. To the best of our knowledge, our present work was the most comprehensive one through enrolling all eligible studies.

Herein, we included 50 individual studies, including 40,059 cases and 64,032 controls. Overall, there was no association between KIF6 rs20455 polymorphism and CHD risk. Hamidizadeh et al. found that significant association was found between this gene polymorphism and CHD risk among Caucasian populations \[[@CR43]\], and the result was verified in another study through enrolling 143,000 subjects \[[@CR40]\]. However, no association was found in a meta-analysis, among South Asians, African-Americans, Hispanics, East Asians, and mixed decedent populations \[[@CR39]\]. Furthermore, other recent studies were also found no association existed between this gene polymorphism and CHD risk \[[@CR25], [@CR26], [@CR47]--[@CR49]\]. When we got the subgroup analyses by ethnicity, there was also no association found among Caucasian and Asian populations. While decreased risk of this gene polymorphism and CHD risk was found among mixed populations. Of note, mixed populations means the original studies didn't clarify the race of the subjects or mixed races. This result may be not provided some useful information for clinical deeds. So, further studies should be performed with clearly race or ethnicity stated in their work.

Publication bias was found in some genetic models. The explanations might arise from some aspects. First, our meta-analysis took into consideration only fully published data, and the abstract and conference papers were excluded. Second, this meta-analysis only focused on papers published in Chinese and English language, and some eligible studies which were reported in other languages might be missed. Third, positive results tend to be accepted by journals while negative results are often rejected or not even submitted. We should point out that the publication bias might partly account for the results, but which were not affected deeply. When we adjusted the results using the trim and fill method, the adjusted risk estimate was attenuated but remained significant, indicating the stability of our results.

Some limitations of this meta-analysis should be addressed. Firstly, heterogeneity is a potential problem when interpreting all the results of meta-analysis. Although we minimized the likelihood by performing a careful search for published studies, using the explicit criteria for study inclusion, the significant between-study heterogeneity still existed in most of comparison. The presence of heterogeneity can result from differences in the age distribution, selection of controls, prevalence lifestyle factors and so on. Secondly, only published studies were included in this meta-analysis. Therefore, potential publication bias was existed in some genetic models. Despite the limitations, our meta-analysis significantly increased the statistical power based on substantial data from different studies. The sensitivity analyses outcomes reflected that our results were statistically stable and reliable.

In conclusion, this present meta-analysis suggests that carriers of KIF6 rs20455 polymorphism may irrelative to the risk of CHD. We also observed no compelling evidence of an association between the KIF6 rs20455 SNP and CHD in multiple race/ethnic groups. These findings do not support the clinical utility of testing for the KIF6 rs20455 polymorphism in the primary prevention of CHD and indirectly question whether genotype information at this locus is able to identify subjects most likely to benefit from the use of statins.
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